The Department of Public Works and Government of Services Canada on behalf of the identified users has a requirement for the supply of Respiratory Syncytial Virus (RSV) vaccine for older adults (60 years and older) on an as-and-when requested basis to various Federal, Provincial and Territorial participants from contract award to March 31st, 2025.
AI Analysis
Get a plain-English breakdown of this tender — what they need, who can bid, how to approach it, and tips for small suppliers. Takes a couple of seconds.
Basic information
Reference
WS4557941089-Doc4557970901
Solicitation no.
WS4557941089
Buyer
Department of Public Works and Government Services (PSPC)
Suppliers who have won similar work from this buyer before.
1
BOEHRINGER INGELHEIM ANIMAL HEALTH
2 contracts won· latest May 28, 2025
CAD $36.2M
total awarded
2
Moderna Biopharma Canada Corporation
1 contract won· latest June 30, 2025
CAD $360.5M
total awarded
3
Pfizer Canada ULC
1 contract won· latest January 25, 2023
CAD $39.5M
total awarded
4
SANOFI PASTEUR LIMITED/SANOFI PASTEUR LIMITEE
1 contract won· latest March 30, 2026
CAD $37.8M
total awarded
5
Emergent Product Development Gaithersburg Inc
1 contract won· latest February 25, 2026
CAD $34.2M
total awarded
BOEHRINGER INGELHEIM ANIMAL HEALTH is the most likely incumbent, based on how often and how recently they have won this buyer’s work in this category. To displace them, expect to need a clearly stronger proposition or price.
